Several groundbreaking therapies are transforming blood sugar treatment, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide emerging as promising options. Retatrutide, a twin GIP and GLP-1 receptor stimulant, shows significant body mass decrease coupled with enhanced glucose control. Cagrillintide, another GLP-1 stimulant, is now in clin